MedTrace Logo

Using mHealth to Promote Post-Menstrual Regulation Contraceptive Uptake and Continuation in Bangladesh

NCT02579785 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 972

Last updated 2021-02-25

No results posted yet for this study

Summary

The purpose of this study is to assess whether a mobile phone intervention can be effectively used to improve post menstrual regulation contraceptive uptake and continuation in Bangladesh.

The study will consist of two phases: Phase I: A formative phase to understand barriers to post-abortion contraceptive uptake and continuation and the content and modality of messages most appropriate for women in the study areas; and Phase II: An RCT will be conducted to test the effectiveness of the mHealth intervention developed during the formative phase on contraceptive use.

Conditions

  • Contraception
  • Post-abortion
  • Abortion

Interventions

BEHAVIORAL

Mhealth intervention

A series of ten automated interactive voice messages will be delivered to the participant's mobile phone over a period of 4 months. Messages will be targeted to the method of contraception the participant is using (no-method, condoms, pills, injectable, implant, copper coil). Messages will support uptake of contraception among no-method users. Messages will support existing users to continue their method and to use it correctly and will also encourage participants who are not happy with their method to switch to a different method. All messages will end with five options: Press 1 to repeat the message, press 2 to listen to recorded information about methods of contraception, press 3 to speak to a counsellor, press 4 to tell me you're fine, press 5 to stop receiving these messages.

Sponsors & Collaborators

  • Ipas

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    collaborator OTHER

  • Marie Stopes International

    lead OTHER

Principal Investigators

  • Kathryn Anderson, PhD · Ipas

  • Sadid Nuremowla, PhD · Marie Stopes International

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-19
Primary Completion
2016-07-15
Completion
2016-07-15

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02579785 on ClinicalTrials.gov